Skip to Content
Merck
  • Diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats.

Diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats.

PloS one (2014-10-21)
Yanglei Jia, Gang Xu, Wenjing Zhou, Zhenzheng Wang, Linlin Meng, Songnan Zhou, Xia Xu, Huiqing Yuan, Keli Tian
ABSTRACT

The objective of the present study was to investigate the association between diabetes mellitus and colorectal carcinogenesis as well as the possible mechanism involved in this interaction. Diabetes rat models were induced with a low dose of STZ followed by a low dose of DMH to induce colorectal cancer. The formation of ACF in the colon and the incidence, number and size of tumors were measured. The activity of glycolytic enzymes in colonic tissues was also measured. The results demonstrated that both the total number of ACF and the number of foci that contain a different number of crypts were increased in diabetic rats. At the end of the experimental treatment, the incidence, number and size of tumors were also increased in diabetic rats. Overall, these data indicated that diabetes increased the risk of colorectal cancer. The activity of HK and PK in colonic tissues was increased in diabetic rats, whereas the activity of PDH was decreased. In addition, the activities of these enzymes in intratumor were higher than that of in peritumor. These data indicated that the high rate of glycolysis may play a role in colorectal carcinogenesis in diabetic rats.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Methylene Blue solution, 0.05 wt. % in H2O
Sigma-Aldrich
Methylene blue, certified by the BSC
Sigma-Aldrich
Methylene Blue solution, suitable for microscopy
Sigma-Aldrich
Methylene Blue solution, concentrate according to Ehrlich, concentrated, aqueous solution
Sigma-Aldrich
Methylene Blue solution, suitable for microbiology
Sigma-Aldrich
5,5-Dimethylhydantoin, 97%